查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424356

微生物原料药的全球市场：按宿主、按类型、按最终用户、按地区

Global Microbial API Market, By Host, By Type, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

微生物原料药的全球市场规模预计将从 2023 年的 612.1 亿美元增至 2030 年的 961.1 亿美元，预测期内复合年增长率为 6.7%。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 612.1亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 6.70% 2030/2031价值预测 961.1亿美元
图 1. 微生物源 API 的全球市场占有率（%），按地区划分，2023 年
全球微生物原料药市场-IMG1

微生物原料药是指利用细菌、真菌、酵母等各种微生物经由微生物发酵生产的治疗物质或原料原料药。微生物原料药主要有两大类：低分子原料药和高分子原料药。小分子原料药是小分子治疗物质，通常透过化学合成生产。大分子原料药，俗称生技药品，是透过重组DNA技术或受管制微生物发酵生产的复杂治疗物质，如单株抗体、疫苗、血液因子等。

大分子微生物原料药与小分子原料药相比具有一定的优点。标靶特异性高、毒性低，对癌症、糖尿病等慢性疾病有较好的治疗效果。此外，使用活微生物的聚合微生物製剂的製造过程可以灵活生产与个人化医疗相容的各种产品。

市场动态：

由于成本效益，对学名药的需求不断增长，推动了全球微生物原料药市场。此外，微生物发酵在反应特异性、生产率和产率方面比化学合成具有优势，促使製药公司加大对微生物原料药生产的投资。然而，建立和开发微生物发酵设施以及扩大聚合微生物原料药的生产流程的高资本要求是复杂且资本集中的，以及严格的监管流程，这些都是预计限製成长的一些因素。

降低製造成本的创新发酵技术的发展为微生物原料药製造商提供了利润丰厚的机会。此外，作为生物製品，除非在严格的品管下生产，否则很容易出现杂质和批次间的差异。这增加了大分子微生物原料药的监管障碍并增加了商品成本。

按地区划分，北美由于医疗费用高且获得良好的医疗服务而占据市场主导地位。然而，在中国和印度等国家的推动下，亚太地区是成长最快的市场。这一增长归因于经济成长、可支配收入增加、医疗基础设施扩大以及生技药品需求增加。

本研究的主要特点

  • 该报告对全球微生物原料药市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球微生物活性原料药市场的主要企业。
  • 该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人明智的决策。
  • 全球微生物原料药市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球微生物原料药市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第 3 章 关键产业见解

  • 市场动态
  • 促进因素
  • 抑制因素
  • 机会
  • 影响分析
  • PEST分析
  • 波特的分析
  • 技术进步
  • 合併、收购和合作场景
  • 最近的产品核准/发布
  • 公司市场占有率分析

第四章 全球微生物原料药市场（依主办单位）2018-2030 年

  • 哺乳动物的
  • 细菌
  • 菌

第五章全球微生物原料药市场，依类型，2018-2030

  • 抗体
  • 胜肽
  • 蛋白质
  • 低分子
  • 疫苗

第 6 章 全球微生物原料药市场，依地区划分，2018-2030 年

  • 公司内部
  • 外包

第七章 全球微生物原料药市场，依最终使用者划分，2018-2030 年

  • 製药公司年份
  • 生物製药公司年份
  • 其他的

第八章全球微生物原料药市场，依分子，2018-2030

  • 新药
  • 非专利的

第9章2018-2030年全球微生物原料药市场（按地区）

  • 按地区
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第十章公司简介-微生物原料药市场

  • KOLON LIFE SCIENCE
    • 公司简介
    • 产品/服务组合
    • 财务绩效
    • 最新动态/最新讯息
    • 策略概览
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lonza
  • Merck & Co., Inc.
  • Topfond Pharmaceutical Co., Ltd.
  • DSM
  • CSPC Pharmaceutical Group Limited

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6508

The global microbial API market size is expected to reach US$ 96.11 Bn by 2030, from US$ 61.21 Bn in 2023, at a CAGR of 6.7% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 61.21 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.70% 2030/2031 Value Projection: US$ 96.11 Bn
Figure 1. Global Microbial API Market Share (%), by Region, 2023
Global Microbial API Market - IMG1

Microbial APIs refer to therapeutic substances or active pharmaceutical ingredients produced through microbial fermentation using various microorganisms such as bacteria, fungi, or yeast. There are mainly two types of microbial APIs: small molecule APIs and large molecule APIs. Small molecule APIs are low-molecular-weight therapeutic substances that are usually produced through chemical synthesis. Large molecule APIs, commonly known as biologics, are complex therapeutic substances like monoclonal antibodies, vaccines, blood factors, etc. that are produced by recombinant DNA technology or controlled microbial fermentation.

Large molecule microbial APIs have certain advantages over small molecule APIs. Due to their high target specificity and lower toxicity, they provide better treatment outcomes for chronic diseases like cancer, diabetes, etc. The manufacturing process of large molecule microbial APIs using living microbes also allows for flexible production of a wide range of product variants catering to personalized medicine.

Market Dynamics:

The global microbial API market is driven by the rising demand for generic and biosimilar drugs owing to cost efficiency. Moreover, microbial fermentation offers advantages over chemical synthesis in terms of reaction specificity, productivity, and yields, which is encouraging pharmaceutical manufacturers to increase investment in microbial API production. However, the high capital requirement for setting up microbial fermentation facilities, developing, and scaling up the manufacturing process of large molecule microbial APIs is complex and capital-intensive and stringent regulatory processes are some of the factors expected to restrain market growth.

The development of innovative fermentation technologies to decrease production costs presents lucrative opportunities for microbial API manufacturers. Additionally, being biological products, they are more prone to impurities and batch-to-batch inconsistencies if not manufactured under stringent quality controls. This raises regulatory hurdles and the cost of goods for large molecule microbial APIs.

Among regions, North America dominates the market due to high healthcare expenditures and better access to care. However, Asia Pacific is poised to be the fastest-growing market arena, led by countries like China and India. This growth can be attributed to growing economies, rising disposable incomes, expanding medical infrastructure, and increasing demand for biologics.

Key features of the study:

  • This report provides in-depth analysis of the global microbial API market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global microbial API market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., Topfond Pharmaceutical Co., Ltd., DSM, CSPC Pharmaceutical Group Limited., KOLON LIFE SCIENCE, Teva Pharmaceutical Industries Ltd., Lonza, Akums Lifesciences Ltd., AbbVie Inc., Xellia Pharmaceuticals, BASF, Dr. Reddy's Laboratories and Lupin
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global microbial API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbial API market

Detailed Segmentation:

Global Microbial API Market

  • By Host
    • Mammalian
    • Bacterial
    • Fungal
  • By Type
    • Antibody
    • Peptide
    • Protein
    • Small Molecule
    • Vaccine
  • By Site
    • In-house
    • Outsourced
  • By End User
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top companies in Global Microbial API Market:
    • Merck & Co., Inc.
    • Topfond Pharmaceutical Co., Ltd.
    • DSM
    • CSPC Pharmaceutical Group Limited.
    • KOLON LIFE SCIENCE
    • Teva Pharmaceutical Industries Ltd.
    • Lonza
    • Akums Lifesciences Ltd.
    • AbbVie Inc.
    • Xellia Pharmaceuticals
    • BASF
    • Reddy's Laboratories
    • Lupin

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Top 3 Market Findings
    • Top 3 Market Opportunity

3. Key Industry Insights

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals/Launches
  • Company Market Share Analysis

4. Global Microbial API Market, By Host, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Mammalian, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Bacterial, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Fungal, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

5. Global Microbial API Market, By Type, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Antibody, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Peptide, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Protein, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Small Molecule, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Vaccine, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

6. Global Microbial API Market, By Site, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • In-house, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Outsourced, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

7. Global Microbial API Market, By End user, 2018-2030, (US$ Bn)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Pharmaceutical Companies, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Biopharmaceutical Companies, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Others, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

8. Global Microbial API Market, By Molecule, 2018 - 2030 ( US$ Billion)

  • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • Innovative, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Generic, 2018 - 2030( US$ Billion)
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

9. Global Microbial API Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2018 - 2030, ( US$ Billion)
    • Segment Trends
  • By Region
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • North America
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.S.
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Canada
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Europe
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • U.K
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Germany
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • France
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Italy
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Spain
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Russia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Europe
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • China
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • India
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Japan
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Australia
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • South Korea
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • ASEAN
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Asia Pacific
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Latin America
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • Brazil
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Mexico
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Argentina
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Latin America
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Middle East
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Molecule, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • GCC
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Israel
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Rest of Middle East
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Africa
    • Introduction
    • Market Size and Forecast, By Host, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Type, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Site, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By End-use, 2018 - 2030, ( US$ Billion)
    • Market Size and Forecast, By Country, 2018 - 2030, ( US$ Billion)
  • North Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • Central Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)
  • South Africa
    • Introduction
    • Market Size and Forecast, 2018 - 2030, ( US$ Billion)

10. Company Profiles - Microbial API Market

  • KOLON LIFE SCIENCE*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Lonza
  • Merck & Co., Inc.
  • Topfond Pharmaceutical Co., Ltd.
  • DSM
  • CSPC Pharmaceutical Group Limited

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact